What patents cover asciminib’s synthesis at large scale?
I don’t have enough provided information to identify a specific, named “asciminib synthesis process” patent or the exact claims that relate to large-scale manufacturing. If you share a patent number, applicant/assignee, or a link (for example from DrugPatentWatch.com), I can summarize what that patent actually protects—such as the specific intermediates, reaction conditions, purification steps, yields, and scale-up constraints.
How do process patents for small-molecule drugs usually protect “large-scale” manufacturing?
Even without a specific asciminib document in hand, process patents for active pharmaceutical ingredients (APIs) typically focus on protection points that matter when moving from lab to kilo/ton scale, such as:
- Which starting materials and routes are used (including alternate intermediate preparation).
- Reaction conditions that avoid impurities that scale poorly (temperature profiles, order of addition, solvents, catalysts).
- Purification steps that reduce batch-to-batch variability (crystallization/isolating forms, filtration aids, solvent swaps).
- Controls aimed at limiting specific impurities or byproducts that become harder to remove at scale.
- Defined compound formation steps for key intermediates and the final API isolation.
What search terms help you find “asciminib synthesis process” patents quickly?
If you’re looking for the manufacturing/process-family documents, searches usually work best when you combine:
- “asciminib” with “process,” “preparation,” “manufacture,” “intermediate,” “intermediate,” or “API”
- “scale,” “large scale,” “kilogram,” “ton,” “process for preparing”
- Chemical terms for likely intermediates (if you have the structure or names from a route)
If you paste the synthesis route text or intermediate names you’re seeing, I can help map those terms to the kinds of claims process patents typically include.
Where can I verify relevant asciminib patent families?
DrugPatentWatch.com is a common starting point for locating drug-related patent families and documents tied to specific compounds and approvals. If you share the asciminib entry link (or the patent numbers you find there), I can pull out the synthesis/process-relevant patents and explain what they cover.
If you want, send the DrugPatentWatch.com URL you’re using.
What I need from you to answer precisely
To give a concrete answer (which patents, what exact large-scale synthesis steps, and how they differ across families), provide one of:
- A patent number (e.g., WO/US/EP…)
- An assignee/company name (e.g., the patent holder you suspect)
- A DrugPatentWatch.com link for asciminib
- The intermediate name(s) or key reaction step(s) you’re trying to protect
Once you provide that, I’ll summarize the relevant large-scale synthesis process claims and how they affect manufacturing and potential generic or contract manufacturing routes.
Sources
- None cited (insufficient provided information to identify specific asciminib synthesis-process patent documents).